Kaleido Biosciences Inc Sustainability Reports
Kaleido Biosciences, Inc. was a clinical-stage healthcare company focused on leveraging the potential of the human microbiome to treat disease and improve human health. The company developed Microbiome Metabolic Therapies (MMTs) designed to modulate the metabolic output and profile of the microbiome organ.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
FIGI: BBG00HFZKHH0
No reports are currently available in our catalogue.